🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06765226
Recruiting Observational

Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps

NCT06765226 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2025-09-21
Last updated
2025-10-03

Condition(s) studied

Heart Failure

Study summary

Analysis of cell and protein deposits on the Impella Heart Pump.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients with Impella 5.5 therapy and duration of support for ≥ 25 days OR Patients with Impella CP therapy and duration of support for \> 4 days Exclusion Criteria: * Age \< 18 years

Primary outcome measure(s)

Trial sites (7)

FacilityCityRegionStatus
Universitätsklinikum Heidelberg Heidelberg Baden-Wurttemberg Not Yet Recruiting
Universitätsklinikum Düsseldorf Düsseldorf North Rhine-Westphalia Not Yet Recruiting
Herzzentrum Dresden Dresden Saxony Not Yet Recruiting
Herzzentrum Leipzig Leipzig Saxony Not Yet Recruiting
Deutsches Herzzentrum der Charité Berlin Berlin Germany Recruiting
Uniklinik Köln Cologne Germany Not Yet Recruiting
Westdeutsches Herz- und Gefäßzentrum Essen Essen Germany Not Yet Recruiting

More Abiomed Inc. trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06765226 on ClinicalTrials.gov ↗ ← All trials in Germany